VascVersa Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $600K

  • Investors
  • 9

VascVersa General Information

Description

Developer of regenerative medicine designed to deliver new cell therapies that promote vascular regeneration and repair. The company's technology provides a unique cell therapy for blood vessel regeneration by stimulating new blood vessel formation, leading to an improved blood supply and long-term healing, enabling healthcare professionals to treat patients suffering from ischaemic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 63 University Road
  • Belfast BT7 1NF
  • Northern Ireland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 63 University Road
  • Belfast BT7 1NF
  • Northern Ireland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VascVersa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 09-Aug-2022 $600K Completed Generating Revenue
5. Grant 01-Feb-2022 Completed Generating Revenue
4. Early Stage VC 01-Apr-2021 Completed Generating Revenue
3. Grant 01-Feb-2020 Completed Startup
2. Accelerator/Incubator 01-Jan-2020 $261K $261K Completed Startup
1. University Spin-Out 20-Dec-2018 Completed Startup
To view VascVersa’s complete valuation and funding history, request access »

VascVersa Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view VascVersa’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VascVersa Patents

VascVersa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202501461-D0 Cells for treatment of ischemic disease Pending 31-Jan-2025
WO-2026162769-A1 Cells for treatment of ischemic disease Pending 31-Jan-2025
AU-2024317407-A1 Cell culture methods and composition Pending 28-Jul-2023
EP-4753723-A1 Cell culture methods and composition Pending 28-Jul-2023
WO-2025026877-A1 Cell culture methods and composition Inactive 28-Jul-2023 C12N5/069
To view VascVersa’s complete patent history, request access »

VascVersa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VascVersa Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
College Green Ventures Venture Capital Minority
Innovation Investment Fund Venture Capital Minority
Invest Northern Ireland Limited Partner Minority
Clarendon Fund Managers Venture Capital Minority
Halo Business Angel Network Angel Group Minority
You’re viewing 5 of 9 investors. Get the full list »

VascVersa FAQs

  • When was VascVersa founded?

    VascVersa was founded in 2018.

  • Where is VascVersa headquartered?

    VascVersa is headquartered in Belfast, United Kingdom.

  • What is the size of VascVersa?

    VascVersa has 6 total employees.

  • What industry is VascVersa in?

    VascVersa’s primary industry is Drug Discovery.

  • Is VascVersa a private or public company?

    VascVersa is a Private company.

  • What is the current valuation of VascVersa?

    The current valuation of VascVersa is .

  • What is VascVersa’s current revenue?

    The current revenue for VascVersa is .

  • How much funding has VascVersa raised over time?

    VascVersa has raised $1.21M.

  • Who are VascVersa’s investors?

    College Green Ventures, Innovation Investment Fund, Invest Northern Ireland, Clarendon Fund Managers, and Halo Business Angel Network are 5 of 9 investors who have invested in VascVersa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process